Clinical Trials
3 trialsNCT04799847 2023-02-13
Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine
LintonPharm Co.,Ltd.
Phase 1/2 Unknown
NCT04222114 2023-01-31
Comparing the Efficacy and Safety of Intra-peritoneal Infusion of Catumaxomab and Treatment of Investigator Choice in Patients With Advanced Gastric Carcinoma With Peritoneal Metastasis
LintonPharm Co.,Ltd.
Phase 3 Unknown
NCT04819399 2022-04-05
Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC
Lindis Biotech GmbH
Phase 1 Unknown